Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 83


Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.

Wilson AJ, Velcich A, Arango D, Kurland AR, Shenoy SM, Pezo RC, Levsky JM, Singer RH, Augenlicht LH.

Cancer Res. 2002 Nov 1;62(21):6006-10.


Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells.

Heruth DP, Zirnstein GW, Bradley JF, Rothberg PG.

J Biol Chem. 1993 Sep 25;268(27):20466-72.


Cdx1 inhibits human colon cancer cell proliferation by reducing beta-catenin/T-cell factor transcriptional activity.

Guo RJ, Huang E, Ezaki T, Patel N, Sinclair K, Wu J, Klein P, Suh ER, Lynch JP.

J Biol Chem. 2004 Aug 27;279(35):36865-75. Epub 2004 Jun 23.


Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.

Sasaki T, Suzuki H, Yagi K, Furuhashi M, Yao R, Susa S, Noda T, Arai Y, Miyazono K, Kato M.

Cancer Res. 2003 Feb 15;63(4):801-6.


ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells.

Huang WS, Wang JP, Wang T, Fang JY, Lan P, Ma JP.

World J Gastroenterol. 2007 Dec 28;13(48):6581-7.


TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent.

Vietor I, Kurzbauer R, Brosch G, Huber LA.

J Biol Chem. 2005 Dec 2;280(48):39795-801. Epub 2005 Oct 3.


A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene.

Gerner EW, Ignatenko NA, Lance P, Hurley LH.

Ann N Y Acad Sci. 2005 Nov;1059:97-105. Review.


Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.

Fujisawa T, Sugiyama M, Tomimoto A, Wada K, Endo H, Takahashi H, Yoneda K, Yoneda M, Inamori M, Saito S, Terauchi Y, Kadowaki T, Tsuchiya N, Nakagama H, Nakajima A.

J Pharmacol Sci. 2008 Dec;108(4):535-44. Epub 2008 Dec 10.


Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents.

Tao L, Kramer PM, Wang W, Yang S, Lubet RA, Steele VE, Pereira MA.

Carcinogenesis. 2002 Sep;23(9):1447-54.


The chemopreventive agent sulindac attenuates expression of the antiapoptotic protein survivin in colorectal carcinoma cells.

Zhang T, Fields JZ, Ehrlich SM, Boman BM.

J Pharmacol Exp Ther. 2004 Feb;308(2):434-7. Epub 2003 Nov 10.


Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.

Souazé F, Viardot-Foucault V, Roullet N, Toy-Miou-Leong M, Gompel A, Bruyneel E, Comperat E, Faux MC, Mareel M, Rostène W, Fléjou JF, Gespach C, Forgez P.

Carcinogenesis. 2006 Apr;27(4):708-16. Epub 2005 Nov 19.


beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.

Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ.

Cancer Res. 2003 Jun 15;63(12):3145-53.


NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.

Kim YJ, Yoon SY, Kim JT, Song EY, Lee HG, Son HJ, Kim SY, Cho D, Choi I, Kim JH, Kim JW.

Carcinogenesis. 2009 Apr;30(4):598-605. doi: 10.1093/carcin/bgp047. Epub 2009 Feb 23.


Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.

Xiang D, Wang D, He Y, Xie J, Zhong Z, Li Z, Xie J.

Anticancer Drugs. 2006 Aug;17(7):753-62.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk